Showing results (2791-2800 of 6,794) with videos related to

Sort By:
Pageof 680
Clinical Therapeutics|February 14, 2007
Tramadol 37.5-mg/acetaminophen 325-mg combination tablets added to regular therapy for rheumatoid arthritis pain: a 1-week, randomized, double-blind, placebo-controlled trialEun Young Lee, Eun Bong Lee, Byung Joo Park, et al.
Clinical Therapeutics|February 14, 2007
The efficacy of cefditoren pivoxil in the treatment of lower respiratory tract infections, with a focus on the per-pathogen bacteriologic response in infections caused by Streptococcus pneumoniae and Haemophilus influenzae: a pooled analysis of seven clinical trialsJuan José Granizo, María José Giménez, José Barberán, et al.
Clinical Therapeutics|February 14, 2007
Two open-label, randomized, crossover studies assessing the bioequivalence of ofloxacin administered as immediate-and extended-release formulations in healthy subjectsJean-Francois Marier, Murray P Ducharme, Marika DiMarco, et al.
Clinical Therapeutics|December 13, 2006
A multicenter, randomized, double-blind, parallel-group trial of the antihypertensive efficacy and tolerability of a combination of once-daily losartan 100 mg/hydrochlorothiazide 12.5 mg compared with losartan 100-mg monotherapy in the treatment of mild to severe essential hypertensionGilbert W Gleim, Joseph Rubino, Hongyan Zhang, et al.
Clinical Therapeutics|December 13, 2006
Drug administration frequency and provider office visit patterns for oncology patients during treatment with erythropoietic agents: an analysis of four observational studiesAntoine Gosselin, Chris L Pashos, Carolyn Harley, et al.
Clinical Therapeutics|January 11, 2007
Bevacizumab: an angiogenesis inhibitor for the treatment of solid malignanciesTed Shih, Celeste Lindley
Clinical Therapeutics|January 11, 2007
Effects of receipt of chronic statin therapy before the onset of acute myocardial infarction: a retrospective study in patients undergoing primary percutaneous coronary interventionHideki Ishii, Satoshi Ichimiya, Masaaki Kanashiro, et al.
Clinical Therapeutics|January 11, 2007
Remission versus response as the goal of therapy in ADHD: a new standard for the field?Margaret Steele, Peter S Jensen, Declan M P Quinn
Clinical Therapeutics|July 10, 2007
A phase I, randomized, open-label, crossover study of the single-dose pharmacokinetic properties of guanfacine extended-release 1-, 2-, and 4-mg tablets in healthy adultsDennis Swearingen, Michael Pennick, Amir Shojaei, et al.
Clinical Therapeutics|July 10, 2007
Formation of neutralizing antibodies in patients receiving botulinum toxin type A for treatment of poststroke spasticity: a pooled-data analysis of three clinical trialsStuart A Yablon, Allison Brashear, Mark F Gordon, et al.
Pageof 680